Efficacy of combined bland embolization and chemoembolization for huge (≥10 cm) hepatocellular carcinoma.

• Material Type: 博士論文
• ISSN: 1364-5706
• Title: Efficacy of combined bland embolization and chemoembolization for huge (≥10 cm) hepatocellular carcinoma.
• Volume: 30 4
• Author/Editor: Hidaka, Teruyuki; Anai, Hiroshi; Sakaguchi, Hiroshi; Sueyoshi, Satoru; Tanaka, Toshihiro; Yamamoto, Kiyosei; Morimoto, Kengo; Nishiofuku, Hideyuki; Maeda, Shinsaku; Nagata, Takeshi; Kichikawa, Kimihiko
• Author Heading: Hidaka, Teruyuki; Anai, Hiroshi; Sakaguchi, Hiroshi; Sueyoshi, Satoru; Tanaka, Toshihiro; Yamamoto, Kiyosei; Morimoto, Kengo; Nishiofuku, Hideyuki; Maeda, Shinsaku; Nagata, Takeshi; Kichikawa, Kimihiko
• Publication, Distribution, etc.: Taylor & Francis
• Publication Date: 2020-02-07; 30 4
• Publication Date (W3CDTF): 2020-02-07
• Alternative Title: 10cm以上の巨大肝細胞癌に対する、ゼラチンスポンジによる肝動脈塞栓術 (bland TAE) と、Lipiodolと抗癌剤による肝動脈化学塞栓術 (TACE) の併用法の治療効果
• Periodical title: Minimally invasive therapy and allied technologies.
• Degree grantor/type: 奈良県立医科大学
• Date Granted: 2020-06-30
• Date Granted (W3CDTF): 2020-06-30
• Dissertation Number: 乙第1462号
• Degree Type: 博士（医学）
• Conferring No. (Dissertation): 乙第1462号
• Text Language Code: eng
• Subject Heading: huge hepatocellular carcinoma; transarterial chemoembolization; bland embolization
• Target Audience: 一般
• Note (General): type:Thesis; Introduction: To assess the efficacy of combined therapy involving bland transarterial embolization using gelatin sponge particles (bland GS-TAE) followed by transarterial chemoembolization using lipiodol mixed with anticancer agents and GS particles (Lip-TACE) to reduce the adverse events and increase the therapeutic effect of Lip-TACE in the treatment of huge (≥10 cm) hepatocellular carcinoma (HCC).Material and methods: Twenty-one consecutive patients with huge HCCs (≥10 cm in diameter) were enrolled in this study. First, bland GS-TAE was performed to reduce the tumor volume, and then Lip-TACE was performed to control the remaining tumor at intervals of around three weeks. Tumor response, survival, and adverse events of this combined therapy were assessed.Results: The tumor response was assessed three months after combined TACE, with complete response in 38.1% and partial response in 57.1% of cases. Severe adverse events were seen in two patients, acute cholecystitis and tumor rupture. The median survival time was 2.7 years, and the one-, two-, three-, and five-year overall survival rates were 76.2%, 66.7%, 42.9%, and 25.0%, respectively.Conclusion: Combined therapy involving bland GS-TAE followed by Lip-TACE can be performed safety and may improve survival in patients with huge HCCs.; 博士（医学）・乙第1462号・令和2年6月30日; © 2020 Society of Medical Innovation and Technology; This is a post-peer-review, pre-copyedit version of an article published in Minimally invasive therapy and allied technologies. The final authenticated version is available online at: https://doi.org/10.1080/13645706.2020.1725580.; identifier:Minimally invasive therapy and allied technologies Vol.30 No.4 p.221-228 (2021 Aug); identifier:13645706; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/3763; identifier:Minimally invasive therapy and allied technologies., 30(4): 221-228
• DOI: info:doi/10.1080/13645706.2020.1725580; https://doi.org/info:doi/10.1080/13645706.2020.1725580
• Persistent ID (NDL): info:ndljp/pid/12263267; https://dl.ndl.go.jp/pid/12263267
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文; https://dl.ndl.go.jp/collections/A00014
• Acquisition Basis: 博士論文（自動収集）
• Date Accepted (W3CDTF): 2022-05-09T11:57:37+09:00
• Format (IMT): application/pdf
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Periodical Title (URI): http://hdl.handle.net/10564/3763
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp

Table of Contents

2023-12-07 再収集

2023-12-07 再収集

2023-12-07 再収集

2023-12-07 再収集

2023-12-07 再収集